These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29027)

  • 21. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 23. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A diffusion method to find the antimicrobial sensitivity of Bacteroides fragilis. Comparative study with a plate dilution technic].
    de la Torre Misiego F; López Bartolome O; Betriu Cabecerán C; Rodríguez Avial C; Cogollos Agruña R
    Rev Clin Esp; 1984 Aug 15-31; 174(3-4):103-5. PubMed ID: 6515069
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
    Martin MA; Liebana J; Castillo AM; Gutierrez J; Piédrola G
    Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    J Chemother; 1989 Jul; 1(4 Suppl):106-7. PubMed ID: 16312326
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial activity and synergism of cefuroxime on anaerobic bacteria.
    Thadepalli H; White DW; Bach VT
    Chemotherapy; 1981; 27(4):252-8. PubMed ID: 7249787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Bacteroides fragilis to spectinomycin.
    Phillips I; Warren C
    J Antimicrob Chemother; 1975 Mar; 1(1):91-5. PubMed ID: 240793
    [No Abstract]   [Full Text] [Related]  

  • 30. The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
    Wise R; Gillett AP; Andrews JM
    J Antimicrob Chemother; 1979 May; 5(3):301-6. PubMed ID: 113377
    [No Abstract]   [Full Text] [Related]  

  • 31. Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.
    Drasar FA; Farrell W; Howard AJ; Hince C; Leung T; Williams JD
    J Antimicrob Chemother; 1978 Sep; 4(5):445-50. PubMed ID: 308506
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
    Esposito S; Gupta A; Thadepalli H
    Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
    de Barbeyrac B; Quentin C; Bebear C
    Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
    Kays MB; White RL; Friedrich LV; Del Bene VE
    Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quaternary heterocyclylamino beta-lactams. II. The in vitro antibacterial properties of L-640,876, a new type of beta-lactam antibiotic.
    Koupal LR; Weissberger B; Shungu DL; Weinberg E; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):47-53. PubMed ID: 6088458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    Med Klin; 1978 Mar; 73(12):423-7. PubMed ID: 347234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of antibiotic activities by using serum bactericidal activity over time.
    Guglielmo BJ; Rodondi LC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1511-4. PubMed ID: 3056237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical analysis of the effects of trial, reader, and replicates on MIC determination for cefoxitin.
    Wexler HM; Lavin PT; Molitoris E; Finegold SM
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2246-9. PubMed ID: 2073115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.